Skip to content

Effects of structuring doctor-patient-communication in primary care of patients with multimorbidity (MultiCare AGENDA)

Effects of structuring doctor-patient-communication in primary care of patients with multimorbidity (MultiCare AGENDA): a multi-center, parallel group, cluster-randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN46272088
Enrollment
600
Registered
2011-11-28
Start date
2011-09-01
Completion date
Unknown
Last updated
2018-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multimorbidity Not Applicable

Interventions

The intervention consists of three special consultations by GPs for patients with multimorbidity. The consultations comprise of: 1. Performing a narrative doctor-patient-dialogue aimed at carving ou

Sponsors

German Federal Ministry of Education and Research (Germany)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age 65 ? 85 years at time of recruitment 2. At least one contact with the GP within the most recent quarter (3 months period)

Exclusion criteria

Exclusion criteria: 1. Poorly known patients to the general practitioner (GP) because of accidental consultation 2. Patients that are treated by the GP for less than 12 months 3. Patients with less than 3 diagnoses out of a list of 42 groups of chronic diseases and syndromes 4. Insufficient ability to consent (e.g. dementia) 5. Insufficient ability to participate in studies (e.g. severe psychic illness) 6. Severe illness probably fatal within 3 months according to the GP 7. Residence in a nursing home 8. Deafness 9. Insufficient ability to speak and read German 10. Participation in other scientific trials

Design outcomes

Primary

MeasureTime frame
1. Number of pharmaceutical agents taken by the patient 2. Health related quality of life as measured by the EuroQoL EQ-5D, UK value set Measured at baseline and post intervention (12 months)

Secondary

MeasureTime frame
1. GPs knowledge of the medication taken by patient 2. Patient satisfaction with GP services as measured by the EUROPEP questionnaire 3. Patient empowerment as measured by the Health Care Empowerment Questionnaire 4. Health care utilization (e.g. contacts with GP and specialists, hospital admissions) Measured at baseline and post intervention (12 months)

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 24, 2026